{"id":"fb402947-296f-422d-b10a-5e449ff3ca4c","modelId":"34aec096-0484-4591-b8c1-f65bd183344f","versionId":null,"locationId":"0001cb7c-b5db-4b49-8051-916c482254c7","operatorId":"6bbb447e-0278-4ae1-822d-8b546420511e","ownerId":null,"slug":"cmr-versius-australia","status":"operational","firstSeen":"2021-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/CMR_Surgical","name":"Wikipedia","title":"CMR Surgical"},{"url":"https://www.surgicalroboticstechnology.com/news/cmr-surgical-announces-installation-of-its-first-versius-surgical-robotic-system-in-australia/","name":"Surgical Robotics Technology","title":"CMR Surgical Announces Installation of Versius In Australia"}],"notes":"Macquarie University Hospital introduced the Versius robotics arm for keyhole surgery in 2021, following TGA approval. First Versius installation in Australia for gynaecological and urogynaecological procedures.","keyFacts":[{"label":"First hospital","value":"Macquarie University Hospital"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-07T05:32:07.747Z","updatedAt":"2026-08-09T04:16:46.351Z","model":{"id":"34aec096-0484-4591-b8c1-f65bd183344f","companyId":"6bbb447e-0278-4ae1-822d-8b546420511e","modelName":"Versius","slug":"cmr-versius","description":"CMR Surgical (founded 2014, Cambridge, UK; private) makes Versius, the genuine challenger among surgical-robot startups and the one that has clearly crossed the regulatory gating event. Versius is a modular multi-arm teleoperated soft-tissue robot that is heavily software-driven, capturing telematic, video, and outcome data. It received US FDA De Novo marketing authorization in October 2024, the first such authorization for a multi-port soft-tissue general-surgery robot, followed by an FDA 510(k) clearance for the next-generation Versius Plus on December 18, 2025 with US commercialization on track for 2026, and a pending gynecology 510(k) submitted on April 29, 2026; it has long been CE-marked and commercial across Europe, Latin America, the Africa-Middle-East region, and Australia, with more than 40,000 procedures completed outside the US by company reporting. The registry records it at commercial maturity with an active lifecycle. An important current-state correction: the 2021 roughly $3 billion SoftBank-led valuation story is frozen in time, the company went through real restructuring in 2023 with about 350 redundancies, and it was recapitalized with more than $200 million in April 2025, while reported figures of a roughly $3.1 billion 2025 valuation and a potential $4 billion sale are rumor-tier aggregator claims that are not registered. On AI substance the shipped reality is a data-capture and analytics ecosystem with the surgeon in full control; the physical-AI framing is forward-looking, anchored in a March 2026 NVIDIA IGX Thor partnership to evaluate AI for a future Versius, with no autonomous or AI-assisted intraoperative feature cleared or shipped.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"arms":"multi-arm","notes":[{"label":"Verified","value":"CMR Surgical (founded 2014, Cambridge UK; private) makes Versius, the genuine challenger that crossed the gating event: FDA De Novo Oct 2024 (first De Novo for a multi-port soft-tissue general-surgery robot), FDA 510(k) for next-gen Versius Plus Dec 18 2025 (US commercialization on track for 2026), plus a pending gynecology 510(k) (Apr 29 2026). >40,000 procedures completed ex-US (company-reported). Recapitalized with $200M+ in Apr 2025."},{"label":"Current-state correction (peak-era framing stale)","value":"The 2021 ~$3B SoftBank-led valuation story is frozen. The company went through real 2023 restructuring (~350 redundancies). REJECTED as unverified aggregator/rumor-tier: a ~$3.1B 2025 valuation and a ~$4B sale-exploration; current valuation is unconfirmed (cap-flag)."},{"label":"AI-substance: R&D-stage (honest)","value":"Shipped substance = data-capture + analytics ecosystem (teleoperated, surgeon in full control). The 'physical AI' is forward-looking: a Mar 2026 NVIDIA IGX Thor partnership to EVALUATE AI for next-gen Versius (~500 hrs anonymized data contributed). No autonomous/AI-assist intraoperative feature is FDA-cleared or shipped."},{"label":"Claimed but NOT verified","value":"~$3.1B current valuation; ~$4B sale exploration; exact installed unit count (procedure-count >40k is self-reported); any AI-assist feature being commercially available; gynecology indication (submitted, not cleared)."}],"products":"Versius / Versius Plus: modular multi-arm soft-tissue minimal-access robot; teleoperated, software-driven (captures telematic/video/outcome data). FDA De Novo Oct 2024 (Versius, cholecystectomy); FDA 510(k) Dec 18 2025 (Versius Plus, cholecystectomy); 510(k) gynecology submission Apr 29 2026 (pending). CE-marked + commercial across Europe, Latin America, AMEA, Australia.","formFactor":"surgical (modular multi-port / multi-arm teleoperated soft-tissue surgical robot)","fda_clearance":"De Novo marketing authorization in October 2024","clearance_body":"US FDA","procedure_types":"cholecystectomy"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.cambridgeindependent.co.uk/news/cmr-surgical-redundancies","title":"CMR Surgical 2023 redundancies (~350; historical restructuring)","sourceName":"Cambridge Independent"}],"aliases":["Versius","Versius Plus","CMR Versius"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form factor","value":"modular multi-arm teleoperated soft-tissue surgical robot"},{"label":"Procedures completed","value":"more than 40,000 outside the US (company-reported)"},{"label":"FDA authorization","value":"De Novo marketing authorization October 2024"},{"label":"Recapitalization","value":"more than $200 million in April 2025"},{"label":"Restructuring","value":"approximately 350 redundancies in 2023"}],"createdAt":"2026-06-03T20:12:29.087Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"6bbb447e-0278-4ae1-822d-8b546420511e","name":"CMR Surgical","slug":"cmr-surgical","description":"UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.","status":"private (recapitalized $200M+ Apr 2025; current valuation unconfirmed)","founded":2014,"hq":"Cambridge, United Kingdom","hqLat":52.1975846,"hqLng":0.1391537,"hqGeocodedAt":"2026-08-05T00:50:46.343Z","hqAddress":null,"hqPrecision":null,"website":"cmrsurgical.com","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"}],"keyFacts":[{"label":"Product","value":"Versius / Versius Plus modular multi-arm teleoperated surgical robot."},{"label":"Gating events","value":"FDA De Novo Oct 2024; Versius Plus 510(k) Dec 2025; gynecology 510(k) pending."},{"label":"wikidata","value":"https://www.wikidata.org/wiki/Q60775579"},{"label":"wikipedia","value":"https://en.wikipedia.org/wiki/CMR_Surgical"},{"label":"Founded","value":"2014, Cambridge, UK"},{"label":"Key product","value":"Versius surgical robot system"},{"label":"FDA clearance","value":"Versius Plus secured"}],"aliases":["CMR","Cambridge Medical Robotics","Versius"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:12:28.328Z","updatedAt":"2026-08-05T02:17:05.420Z"}},"version":null,"location":{"id":"0001cb7c-b5db-4b49-8051-916c482254c7","name":"Australia","slug":"australia","kind":"country","parentLocationId":null,"region":null,"lat":-25.2744,"lng":133.7751,"reviewStatus":"reviewed","aliases":["AU"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-31T04:22:21.509Z","updatedAt":"2026-08-09T01:48:06.904Z"},"operator":{"id":"6bbb447e-0278-4ae1-822d-8b546420511e","name":"CMR Surgical","slug":"cmr-surgical","description":"UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.","status":"private (recapitalized $200M+ Apr 2025; current valuation unconfirmed)","founded":2014,"hq":"Cambridge, United Kingdom","hqLat":52.1975846,"hqLng":0.1391537,"hqGeocodedAt":"2026-08-05T00:50:46.343Z","hqAddress":null,"hqPrecision":null,"website":"cmrsurgical.com","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"}],"keyFacts":[{"label":"Product","value":"Versius / Versius Plus modular multi-arm teleoperated surgical robot."},{"label":"Gating events","value":"FDA De Novo Oct 2024; Versius Plus 510(k) Dec 2025; gynecology 510(k) pending."},{"label":"wikidata","value":"https://www.wikidata.org/wiki/Q60775579"},{"label":"wikipedia","value":"https://en.wikipedia.org/wiki/CMR_Surgical"},{"label":"Founded","value":"2014, Cambridge, UK"},{"label":"Key product","value":"Versius surgical robot system"},{"label":"FDA clearance","value":"Versius Plus secured"}],"aliases":["CMR","Cambridge Medical Robotics","Versius"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:12:28.328Z","updatedAt":"2026-08-05T02:17:05.420Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/cmr-versius-australia","url":"https://registry.deploy.report/deployments/cmr-versius-australia","name":"Versius at Australia","identifier":"fb402947-296f-422d-b10a-5e449ff3ca4c","startDate":"2021-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/australia","name":"Australia"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/cmr-surgical","name":"CMR Surgical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/cmr-versius","name":"Versius"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["knowledge-base"]}}}